Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Stock Symbol
-
AGIO on Nasdaq
Sarah Gheuens - trading volume in the past year for Agios Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common stock |
43.7K |
$1.92M |
$43.85 |
Jul 1, 2024 |
Direct |
|
|
Restricted stock units |
16.7K |
$818K |
$48.84 |
Jul 1, 2024 |
Direct |
Common stock |
|
Stock options (right to buy) |
60K |
|
|
Mar 1, 2024 |
Direct |
Common stock |
|
Performance share units |
0 |
|
$21.64 |
Jan 20, 2024 |
Direct |
Common stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.